These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9647471)

  • 81. Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain.
    Beveridge TJ; Mechan AO; Sprakes M; Pei Q; Zetterstrom TS; Green AR; Elliott JM
    Psychopharmacology (Berl); 2004 May; 173(3-4):346-52. PubMed ID: 14735293
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
    Shankaran M; Gudelsky GA
    Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.
    Aguirre N; Barrionuevo M; Lasheras B; Del Río J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1159-65. PubMed ID: 9732373
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
    Rodsiri R; Spicer C; Green AR; Marsden CA; Fone KC
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):365-76. PubMed ID: 20645080
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.
    McGregor IS; Gurtman CG; Morley KC; Clemens KJ; Blokland A; Li KM; Cornish JL; Hunt GE
    Psychopharmacology (Berl); 2003 Aug; 168(4):465-74. PubMed ID: 12700882
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan.
    Sprague JE; Huang X; Kanthasamy A; Nichols DE
    Life Sci; 1994; 55(15):1193-8. PubMed ID: 7934616
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
    Bull EJ; Hutson PH; Fone KC
    Neuropharmacology; 2003 Mar; 44(4):439-48. PubMed ID: 12646281
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.
    Schmidt CJ; Black CK; Abbate GM; Taylor VL
    Brain Res; 1990 Oct; 529(1-2):85-90. PubMed ID: 1980848
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity.
    Li IH; Ma KH; Kao TJ; Lin YY; Weng SJ; Yen TY; Chen LC; Huang YS
    Neurotoxicology; 2016 Jan; 52():114-26. PubMed ID: 26610922
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
    Rodsiri R; Green AR; Marsden CA; Fone KC
    J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats.
    Nisijima K; Kuboshima K; Shioda K; Yoshino T; Iwamura T; Kato S
    Neurosci Lett; 2012 Dec; 531(2):198-203. PubMed ID: 23142720
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy).
    Sprague JE; Banks ML; Cook VJ; Mills EM
    J Pharmacol Exp Ther; 2003 Apr; 305(1):159-66. PubMed ID: 12649364
    [TBL] [Abstract][Full Text] [Related]  

  • 98. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors.
    Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA
    J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").
    Green AR; Cross AJ; Goodwin GM
    Psychopharmacology (Berl); 1995 Jun; 119(3):247-60. PubMed ID: 7675958
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
    Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
    Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.